ICEPHARMA A/S: Financial statements 2022
CVR: 36393459
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
ICEPHARMA A/S (CVR 36393459) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -1,025,961 and a net result of DKK -4,748,115 compared with DKK -5,423,874 the year before. Equity in the 2022 report amounted to DKK 1,647,987. The solvency ratio was 47.1%. The company had 5 employees in the financial year.
- Gross Profit
- DKK -1,025,961
- Profit/Loss
- DKK -4,748,115
- Equity
- DKK 1,647,987
- Total Assets
- DKK 3,501,851
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -1 mio. | -4.7 mio. | 1.6 mio. | 5 |
| 2021 | - | -2.4 mio. | -5.4 mio. | 690 t. | 5 |
| 2020 | - | -2.2 mio. | -5.7 mio. | 7 t. | 5 |
| 2019 | - | -3.9 mio. | -7.7 mio. | 581 t. | 5 |
| 2018 | - | -3.6 mio. | -7.2 mio. | 829 t. | 5 |
Official annual report
Keep an eye on ICEPHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
ICEPHARMA A/S has published its annual report for 2021. Gross profit came to DKK -2,436,032, and the net result was DKK -5,423,874.
About ICEPHARMA A/S
ICEPHARMA A/S is a Danish company of the type Aktieselskab based in Taastrup, founded in 2014. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Hörður Þórhallsson. The board consists of Kristján Johannsson (chair), Jóhann Ingi Kristjánsson and Petrea Ingileif Gudmundsdottir. The company is owned by Eignarhaldsfélagið Lyng ehf. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,000,033 and a net result of DKK 1,883,876 compared with DKK -3,562,543 the year before. Equity in the 2025 report amounted to DKK 10,304,500.